4 ms·
OK, the language was inflammatory and I apologize for that bit. But the point stands: it's not a "marketing" problem that they are providing pseudo-diagnostic
by ajross 13y ago
OK, the language was inflammatory and I apologize for that bit. But the point stands: it's not a "marketing" problem that they are providing pseudo-diagnostic results. That's what the market wants, because they can't get it from the existing products under the existing regulatory structure.
One way to see this is yours and the FDA's: it's a fairness issue, and they need to play by the same rules. The other is the liberstartuptarian line that the regulatory structure is the thing actually at fault here. In this case, I tend to agree with the latter.
I mean, I had fun with this service, and I wasn't fooled by its marketing: they told me in essence that they'd give me their best guess at my traits and disease risks and drug susceptibilities, etc... And I bought it. A product that just gave me a bunch of genes and markers I could look up on wikipedia wouldn't have gotten my money.
So what's the answer here? Where's the regulatory answer for those of us who want to spit in a tube and get a fun HTML5 experience out of it? It doesn't seem like the FDA has one.
- anigbrowl 13y agoThey could slap on a disclaimer saying 'Results for entertainment purposes only. This service has not been evaluated or approved by the FDA.' I'm no expert on regulatory law but I suspect this would immunize them from most oversight...but I also suspect it would have a deleterious effect on sales.
- smackfu 13y agoI think they would have to remove much of the product too. The FDA is involved because they consider the product to be "intended for use in the diagnosis of disease." I doubt they could say, "our data shows you have disease X but this is for entertainment purposes only."
- tptacek 13y agoYou're right. They're not going to be able to say "our data shows you have disease X". They probably have no business saying anything of the sort.
- DanBC 13y ago> That's what the market wants, because they can't get it from the existing products under the existing regulatory structure. The market can have that, all 23andMe has to do is stop selling their product as a diagnostic test. They sell it as being able to predict your risk of some diseases. They're not a tiny little startup battling against the industry, they have some pretty big money. They need to either sell it as a novelty ("Not designed to treat or diagnose any medical condition") or step up and get regulated. Unfortunately we're in a weird situation where 23andMe get regulated, but wingnuts like Sarah Myhill (in the UK) don't. http://drmyhill.co.uk/wiki/Nutritional_Supplements_-_what_everybody_should_be_taking_all_the_time_even_if_nothing_is_wrong http://drmyhill.co.uk/wiki/Nutritional_Supplements_-_what_ev... So I definitely agree that something's wrong.
- dragonwriter 13y ago> The market can have that, all 23andMe has to do is stop selling their product as a diagnostic test. Or, alternatively, perform and submit the studies to show that, used as directed, it works as a diagnostic test as marketed.